We have no evidence to infer a direct role for the identified LYST mutation in predisposing to development of myeloid neoplasms; however, we can envision a possible role for a deregulated immune system in controlling the homeostasis of hematopoietic differentiation. The gene discussed is LYST; the disease is myeloid neoplasm.